Andrea Charles
More content by Andrea Charles
Gawayne Mahboubian-Jones on International Standards to Support the Application of Process Analytical Technology
January 13 by Andrea CharlesIn this interview Gawayne Mahboubian-Jones, Manager of Quality by Design for Philip Morris International, shares his views on international standards to support the application of Process Analytical...
Desmond Hunt on Expectations for the New Chapter from the USP regarding Single-Use Systems
December 11 by Andrea CharlesDesmond Hunt, Senior Scientific Liaison, United States Pharmacopoeia (USP), speaks to Andrea Charles from Pharma IQ, about the current standards and guidance for single-use systems and the expectati...
New Territory: Extractables & Leachables in Disposable and Single-Use Manufacturing Systems
November 25 by Andrea CharlesIn this exclusive interview Alain Pralong, VP New Product Introduction and Technical Life Cycle Management at GlaxoSmithKline Vaccines, speaks to Andrea Charles from Pharma IQ, about the challenges&...
Pharmaceutical Serialisation - The Global Problem with No Global Solution
August 12 by Andrea CharlesSerialisation is a global problem and the different regional requirements are challenging. In this Pharma IQ interview Pasi Kemppainen, executive consultant for serialisation and traceability and cu...
Pfizer's Timothy Dunne on Attaining the Highest Level of Sample Quality in Compound Management
July 29 by Andrea CharlesEffective management of compound libraries remains crucial for drug innovation and discovery. In this podcast Timothy Dunne, Scientist, Pfizer, speaks to Andrea Charles from Pharma IQ, about the mai...
Planning on Building a Bespoke ELN? Lessons Learnt from the Academic Arena
June 24 by Andrea CharlesStarting with a clean sheet. Allan Jordan, Head of Chemistry at the Paterson Institute for Cancer Research, shares his experiences of building a bespoke ELN with Andrea Charles from Pharma IQ. Jorda...
Merck's Executive Director Christine Brideau on How to Address Biological Sample Management in the Discovery Space
June 18 by Andrea CharlesIn this interview Christine Brideau, Executive Director, Biological Sample Management at Merck, speaks to Andrea Charles from Pharma IQ, about how biological sample management is now being addr...
How To: Scalable Unique Device Identification (UDI) Implementation – Real World Lessons Learnt
June 17 by Andrea CharlesThe FDA Final Rule on UDIs is a critical move forward in utilising and leveraging technology to advance medical device information. In this exclusive interview Dawn Fowler, Sr. Manager, Labeling &am...
Lifting the Veil of Uncertainty: UDIs for Medical Devices
June 14 by Andrea CharlesThe FDA Final Rule on UDIs (unique device identifiers) for medical devices is expected to be published in early August. In May the EU Commission announced their intention to take an intern...
Are we in Danger of Suffering from a Data & Information Overload in Healthcare IT?
June 11 by Andrea CharlesHealthcare informatics is a discipline that is ever-changing from mobile devices, to cloud-based computing to language technology, with the rise in genomics and preventative medicine we ca...
Trends in Computational Toxicology & Critical Success Factors for Transporter Studies
May 30 by Andrea CharlesIn this exclusive interview Tobias Noeske, Associate Principal Scientist from AstraZeneca, speaks to Andrea Charles from Pharma IQ. Noeske describes how AstraZeneca are reducing compound...
Lundbeck's Ludovic Otterbein on Bottlenecks and Best Practices in Compound Management
March 13 by Andrea CharlesEvery company has compound collections of different sizes, but we all face the same challenge of the rising cost of R&D. - Ludovic Otterbein Ludovic Otterbein, Head of Global Compound Man...
